Swiss Long-Term Care Facility Trials Assisted Suicide Amid Ethical Challenges

Switzerland has long positioned "autonomous death" as a final life choice, viewing it as an extension of personal dignity. Since the 1997 revision of the assisted suicide law, the country has permitted assisted suicide under strict conditions, while explicitly prohibiting active euthanasia, which involves physicians directly administering lethal drugs. This legal framework has established Switzerland as a representative of "euthanasia culture" on the international stage; however, the reality is far more complex than external perceptions suggest.

In recent years, some cantonal governments have begun piloting the inclusion of assisted suicide in the service scope of long-term care facilities, particularly in the canton of Aargau. In an exclusive interview with CNA, Lei Fei, the head of the long-term care department at a nursing home in Aargau, noted that while societal acceptance of autonomous death is gradually increasing, it remains a non-mainstream practice. In fact, the natural mortality rate among critically ill patients remains higher than that of any form of assisted suicide. Furthermore, the majority of cases are managed by medical teams through pain relief and symptom management, allowing patients to pass away in relative peace.

Lei Fei further explained that assisted suicide in long-term care settings requires rigorous ethical review and multidisciplinary consultation. Physicians, nursing staff, patient families, and legal advisors must collectively verify that the patient’s wishes are genuine, free from pressure, and capable of repeated confirmation. This process is both time-consuming and resource-intensive, leading many institutions to adopt a cautious stance regarding the integration of this service into their daily operations. Conversely, many patients, as their conditions deteriorate, opt for a natural transition supported by the medical team’s pain control and psychological support, rather than actively seeking to end their lives.

In Switzerland, the distinction between assisted suicide and active euthanasia is stark. According to federal regulations, physicians are limited to providing assistance and guidance and are prohibited from directly administering lethal substances; active euthanasia is considered illegal. This legal nuance is often overlooked in international discourse, leading to misunderstandings about Switzerland’s "euthanasia culture." Lei Fei pointed out that many international media reports focus on the surface-level phenomenon that "Swiss citizens can choose death," while ignoring the underlying medical ethics, legal constraints, and practical operational difficulties.

This discrepancy not only affects domestic understanding of end-of-life care but also influences global policy debates on "autonomous death." Countries such as the United States and Canada frequently cite Switzerland as a reference case when debating the potential relaxation of assisted suicide regulations. However, ignoring Switzerland’s internal conservative attitudes and strict procedural requirements regarding assisted suicide could lead to imbalanced policy formulation. Lei Fei urged that any reforms in end-of-life care must center on patient welfare and medical ethics, avoiding the reduction of "autonomous death" to a selectable commercial service.

In conclusion, while Switzerland is culturally symbolized by "autonomous death," assisted suicide is not the mainstream; critically ill patients predominantly die naturally. Long-term care institutions must navigate multiple legal, ethical, and practical challenges when considering whether to offer such services. For the international community, accurately understanding the differences between Swiss law and practice will facilitate a more rational discussion on end-of-life care and autonomous death. (Source: CNA)